白如玉 李亨芬 聂金梅 邢永梅 邹金 刁勇.以VEGF/VEGFR 为靶点的肺癌治疗药物研究进展[J].现代生物医学进展英文版,2012,12(14):2785-2790. |
以VEGF/VEGFR 为靶点的肺癌治疗药物研究进展 |
Treatments of Lung Cancer Targeting VEGF and VEGFR |
|
DOI: |
中文关键词: 肺癌 血管生成 靶点 VEGF 研究进展 |
英文关键词: Lung cancer Angiogenesis Target VEGF Research |
基金项目:国家自然科学基金项目(30973591);福建省对外合作重点项目(2009I0017);福建省自然科学基金青年人才创新项目
(2011J05080);华侨大学“中央高校基本科研业务费”科研基地专项基金项目资助(JB-JD1003);泉州市科技与开发项目(2011Z5);
华侨大学高层次人才科研启动费项目(09BS624) |
|
Hits: 805 |
Download times: 2736 |
中文摘要: |
目的:论述以血管内皮生成因子(VEGF)及其受体VEGFR 为靶点的肺癌的研究现状,探讨VEGF 及VEGFR 与肺癌发生及
发展的关系,为肺癌抗血管生成的治疗提供新的药物作用途径。方法:依据近年国内外的相关文献,进行归纳和分析,对VEGF 及
肺癌发生相关系统进行研究,并在此基础上,提出肺癌抗血管治疗的新思路。结果:研究发现,在肺癌的发生及发展过程中,VEGF
出现过量表达。为达到抑制其促血管生成的作用,以VEGF/VEGFR 为靶点,研制抑制VEGF 活性的药物或干扰VEGFR 的药物,
可在一定程度上实现通过抑制相关抗血管生成治疗肺癌的目的。结论:利用新的抗血管途径有望在肺癌治疗中研发出新药,提高
肺癌治疗效果。 |
英文摘要: |
Objective: To provide a new way of anti-angiogenic drug treatment for lung cancer by studying the research status of
lung cancer targeting vascular endothelial growth factor (VEGF) and its receptor VEGFR, and discussing the relationship between VEGF/
VEGFR and the occurrence and development of lung cancer. Methods: Summarizing and analyzing the relationship between VEGF and
related systems in lung cancer based on the literatures both at home and abroad in recent years. Results: VEGF is overexpressed in the
development process of lung cancer. To inhibit angiogenesis effect of VEGF/VEGFR, to some extent, some new drugs could be found to
treat the lung cancer. Conclusion: When the new drugs are developed in the new anti-angiogenic pathway, the treatment of lung cancer
will be improved. |
View Full Text
View/Add Comment Download reader |
Close |